SOS1/KRAS inhibitors (Schrodinger)

N/A

Report date: 2025/02/21 14:35:11
NME

Base Information

Drug NameSOS1/KRAS inhibitors (Schrodinger)
Drug Alias NameSOS1/KRAS protein-protein interaction inhibitorSDGR5 programSDGR5-SOS1 / KRAS
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSOS1/KRAS interaction inhibitor
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSchrodinger Inc
China Registration ClassN/A

Develop Information

Active CompaniesSchrodinger Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A